Russian Federation
Russian Federation
Russian Federation
Russian Federation
Russian Federation
The article assesses influence of sodium glucose cotransporter 2 inhibitors in combined therapy of chronic cardiac insufficiency on the levels of biomarkers of myocardial and renal dysfunction, endothelial function and final nitric oxide metabolites content in patients with stable ischemic heart disease with chronic cardiac insufficiency I-III functional classes and renal insufficiency and with or without type 2 diabetes.
sodium glucose cotransporter 2 (SGLT2) inhibitors, soluble tumorigenicity suppressor 2 (sST2), Galectin-3 (Gal-3)
1. Dubolazova Yu.V., Drapkina O.M. Primenenie galektina-3 i NT-proBNP v kachestve biomarkerov dekompensirovannoy serdechnoy nedostatochnosti // Rossiyskiy kardiologicheskiy zhurnal. – 2017. – № 1 (141). – S. 95–101.
2. Podzolkov V.I., Dragomireckaya N.A., Kazadaeva A.V. i dr. Galektin-3 kak marker kardiorenal'nogo sindroma u bol'nyh hronicheskoy serdechnoy nedostatochnost'yu //Racional'naya Farmakoterapiya v Kardiologii. – 2022. – T. 18. - № 2. – S.153-159.
3. Mezhonov E.M., Reytblat O.M., Vyalkina Yu. A. i dr. Hronicheskaya bolezn' pochek i hronicheskaya serdechnaya nedostatochnost': vliyanie na prognoz i vybor patogeneticheskoy terapii // Terapevticheskiy arhiv. – 2024. – T. 96. – № 7. – S. 666–674.
4. Huang Z., Zhong J., Zhang S. et al. Association between serum cystatin C and early impairment of cardiac function and structure in type 2 diabetes patients with normal renal function // Clin Cardiol. – 2022; № 45(12). – R. 1287–1296.
5. Oranzhereeva V.N., Belaya O.L., Kovalenko E.V., Markova L.I., Tereschenko O.I., Kuropteva Z.V. Vozmozhnosti nekotoryh sovremennyh biomarkerov v prognozirovanii neblagopriyatnyh serdechno-sosudistyh sobytiy u bol'nyh ishemicheskoy bolezn'yu serdca i hronicheskoy bolezn'yu pochek // Effektivnaya farmakoterapiya. – 2024. – T. 20. – № 31. – S. 70–75.
6. Boycov S.A., Bubnova M.G., Vasyuk Yu.A. i dr. Hronicheskaya serdechnaya nedostatochnost'. Klinicheskie rekomendacii – 2024 // Rossiyskiy kardiologicheskiy zhurnal. – 2024. – T. 29. – №
7. Algoritmy specializirovannoy medicinskoy pomoschi bol'nym saharnym diabetom. 12-y vypusk / Pod redakciey Dedova I.I., Shestakovoy M.V., Suharevoy O.Yu. // Moskva. – 2025.
8. Hronicheskaya bolezn' pochek. Klinicheskie rekomendacii Nacional'noy associacii nefrologov. – 2024.
9. Oranzhereeva V.N., Belaya O.L., Kovalenko E.V., Fateev S.S., Kuropteva Z.V. Oksid azota, okislitel'nyy stress i endotelial'naya disfunkciya u bol'nyh ishemicheskoy bolezn'yu serdca s hronicheskoy serdechnoy i pochechnoy nedostatochnost'yu i saharnym diabetom 2-go tipa // Medicinskiy vestnik MVD. – 2025. – T. 125. – № 4. – S. 52–56.
10. Arabidze G.G., Polyakova O.V., Puhaeva A.A. i dr. Integraciya vizualizacii i cirkuliruyuschih biomarkerov pri serdechnoy nedostatochnosti: novyy podhod k diagnosticheskomu algoritmu // Uchebno-metodicheskoe posobie. – Moskva. – 2022. – S. 25–26.
11. Huang Z., Zhong J., Zhang S. et al. Association between serum cystatin C and early impairment of cardiac function and structure in type 2 diabetes patients with normal renal function // Clin. Cardiol. – 2022, № 45(12). – P. 1287–1296.
12. Li M., Duan L., Cai Y. et al. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus // Cardiovasc. Diabetol. – 2021. – P. 11.
13. Guo G., Huang A., Huang X. et al. Prognostic value of soluble suppression of tumorigenicity 2 in chronic kidney disease patients: A Meta-Analysis // Dis Markers. – 2021; № 2021. – P. 11.
14. Lidgard B., Zelnickv L., Anderson A. et al. Cardiac biomarkers and risk of atherosclerotic cardiovascular disease in patients with CKD // Kidney 360. – 2022; № 3(5). – P. 859–871. 2
15. Zile M.R., O'Meara E., Claggett V. et al. Effects of sacubitril/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF // J Am Coll Cardiol. – 2019. – 73(7). – P. 795–806.
16. Zile M.R., Jhund P.S., Baicu C.F. et al. Plasma biomarkers reflecting brofibrotic processes in heart failure with a preserved ejection fraction: data from the prospective comparison of ARNI with ARB on management of heart failure with preserved ejection fraction study // Circ Heart Fail. – 2016. – 9(1). – e002551.
17. Kozulina E.S., Viktorova I.A. Endotelial'naya disfunkciya u pacientov s arterial'noy gipertenziey i saharnym diabetom i vozmozhnosti ee korrekcii // RMZh. Medicinskoe obozrenie. – 2025. – T. 9; № 1. – S. 64–68.
